Colony Group’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $1.77M | Buy |
32,948
+102
| +0.3% | +$5.44K | 0.03% | 352 |
|
|
2023
Q2 | $1.77M | Buy |
32,846
+162
| +0.5% | +$8.72K | 0.03% | 364 |
|
|
2023
Q1 | $1.78M | Buy |
32,684
+720
| +2% | +$35K | 0.03% | 363 |
|
|
2022
Q4 | $1.55M | Buy |
31,964
+8,413
| +36% | +$369K | 0.02% | 416 |
|
|
2022
Q3 | $895K | Buy |
23,551
+6,668
| +39% | +$297K | 0.02% | 464 |
|
|
2022
Q2 | $845K | Buy |
16,883
+2,899
| +21% | +$154K | 0.01% | 483 |
|
|
2022
Q1 | $718K | Buy |
13,984
+1,493
| +12% | +$77.1K | 0.01% | 549 |
|
|
2021
Q4 | $626K | Sell |
12,491
-1,934
| -13% | -$95.7K | 0.01% | 540 |
|
|
2021
Q3 | $695K | Buy |
14,425
+1,121
| +8% | +$57K | 0.01% | 499 |
|
|
2021
Q2 | $701K | Sell |
13,304
-894
| -6% | -$46.7K | 0.01% | 455 |
|
|
2021
Q1 | $702K | Buy |
14,198
+1,935
| +16% | +$93K | 0.01% | 457 |
|
|
2020
Q4 | $596K | Sell |
12,263
-120
| -1% | -$5.92K | 0.01% | 469 |
|
|
2020
Q3 | $621K | Buy |
12,383
+3,877
| +46% | +$200K | 0.02% | 437 |
|
|
2020
Q2 | $434K | Sell |
8,506
-87
| -1% | -$4.23K | 0.01% | 482 |
|
|
2020
Q1 | $376K | Buy |
8,593
+1,338
| +18% | +$64K | 0.01% | 513 |
|
|
2019
Q4 | $364K | Buy |
7,255
+2,861
| +65% | +$134K | 0.01% | 584 |
|
|
2019
Q3 | $204K | Buy |
+4,394
| New | +$190K | 0.01% | 672 |
|
|
2017
Q1 | – | Sell |
-5,027
| Closed | -$203K | – | 298 |
|
|
2016
Q4 | $203K | Sell |
5,027
-250
| -5% | -$9.85K | 0.02% | 272 |
|
|
2016
Q3 | $202K | Hold |
5,277
| – | – | 0.02% | 253 |
|
|
2016
Q2 | $221K | Hold |
5,277
| – | – | 0.02% | 227 |
|
|
2016
Q1 | $212K | Buy |
5,277
+4,760
| +921% | +$191K | 0.02% | 230 |
|
|
2015
Q4 | $22K | Sell |
517
-82
| -14% | -$3.77K | ﹤0.01% | 549 |
|
|
2015
Q3 | $28K | Buy |
599
+582
| +3,424% | +$29.6K | ﹤0.01% | 516 |
|
|
2015
Q2 | $1K | Hold |
17
| – | – | ﹤0.01% | 704 |
|
|
2015
Q1 | $1K | Hold |
17
| – | – | ﹤0.01% | 690 |
|
|
2014
Q4 | $1K | Hold |
17
| – | – | ﹤0.01% | 724 |
|
|
2014
Q3 | $1K | Hold |
17
| – | – | ﹤0.01% | 762 |
|
|
2014
Q2 | $1K | Sell |
17
-110
| -87% | -$5.84K | ﹤0.01% | 700 |
|
|
2014
Q1 | $7K | Buy |
127
+110
| +647% | +$5.57K | ﹤0.01% | 607 |
|
|
2013
Q4 | $1K | Buy |
+17
| New | +$877 | ﹤0.01% | 652 |
|
Other funds holding SNY
Colony Group's SNY Position: Q3 2023 in Review
Colony Group increased its Sanofi (SNY) stake by 0.31% in Q3 2023, buying an estimated $5.44K and bringing the position to 32,948 shares worth $1.77M. The position accounts for 0.03% of the portfolio, ranked #352.
Colony Group first reported a position in SNY in Q4 2013 and has held it in 30 quarters since. The position peaked at $1.78M in Q1 2023. 696 funds tracked by Wall St. Rank hold SNY as of Q3 2023.
- Colony Group held 32,948 shares of Sanofi worth $1.77M as of Q3 2023.
- Colony Group bought 102 Sanofi shares in Q3 2023, an estimated $5.44K.
- Sanofi made up 0.03% of Colony Group's portfolio in Q3 2023, its #352 holding.
- Colony Group first reported a position in Sanofi in Q4 2013 and has held it in 30 quarters since.
- Colony Group's Sanofi position peaked at $1.78M in Q1 2023.
- 696 funds tracked by Wall St. Rank held Sanofi as of Q3 2023.
Based on Colony Group's 13F filing for Q3 2023, filed 14 Nov 2023.